MEEKA BOND: Open Payments
NPI 1063934487 · POST FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$267 in 14 payments from 9 companies in 2025. Trend: 2023 $430 · 2024 $396 · 2025 $267
Food & beverage: $267
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $70 |
| Sumitomo Pharma America, Inc. | 4 | $63 |
| Exact Sciences Corporation | 1 | $32 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Ethicon US, LLC | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| COLOPLAST CORP | 1 | $17 |
| Organon LLC | 1 | $14 |
| CooperSurgical, Inc. | 1 | $14 |
Products named: GEMTESA, BOTOX, Cologuard Collection Kit, UBRELVY, NUCALA, VISTASEAL, TEZSPIRE, Altis.
Industry payments across ID — which companies pay providers there.
